
Cat. #156642
Anti-Neonatal Myosin [N1.551]
Cat. #: 156642
Unit size: 100 ug
Availability: 10-12 weeks
Target: MYH8 and some adult fast skeletal muscle myosin heavy chains
Class: Monoclonal
Application: IHC ; WB
Reactivity: Chicken ; Human ; Mouse ; Rat ; Rabbit
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Institute: Medical Research Council; Stanford University
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-Neonatal Myosin [N1.551]
- Alternate name: Various fast skeletal muscle myosin heavy chains
- Class: Monoclonal
- Conjugation: Unconjugated
- Molecular weight: 220000
- Reactivity: Chicken ; Human ; Mouse ; Rat ; Rabbit
- Host: Mouse
- Application: IHC ; WB
- Description: Neonatal myosin heavy chain and some cross-reaciton to adult fast Myhc
- Immunogen: Purified neonatal human skeletal muscle myosin.
- Recommended controls: IgM
Target Details
- Target: MYH8 and some adult fast skeletal muscle myosin heavy chains
- Molecular weight: 220000
- Target background: Neonatal myosin heavy chain and some cross-reaciton to adult fast Myhc
Applications
- Application: IHC ; WB
Handling
- Format: Liquid
- Unit size: 100 ug
- Shipping conditions: Dry ice
References
- Hughes et al. 1993. Dev Biol. 158(1):183-99. PMID: 7687223.

![Anti-CAR Whitlow Linker [1C3C3]](https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-300x322.jpg 300w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-280x300.jpg 280w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-954x1024.jpg 954w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-768x824.jpg 768w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025.jpg 1193w)


